文献速递角膜与眼表疾病

真空干燥羊膜联合纤维蛋白胶改良ACER技术治疗全角膜缘干细胞缺乏症

Management of limbal stem cell deficiency by amnion-assisted conjunctival epithelial redirection using vacuum-dried amniotic membrane and fibrin glue.
PubMed 文献 · Br J Ophthalmol · 2021-10-05

本研究回顾性分析2016–2019年接受改良羊膜辅助结膜上皮重定向(ACER)联合角膜缘干细胞移植(LSCT)的10例全角膜缘干细胞缺乏症(LSCD)患者,80%获得完全或部分成功,20%需重复LSCT,自体LSCT成功率显著高于异体LSCT(p=0.048),最佳矫正视力(logMAR)从术前1.76±0.64显著改善至末次随访0.94±0.94(p=0.009)。真空干燥羊膜(Omnigen)可室温储存、透明且易于操作。

要点

  • 改良ACER联合LSCT治疗全LSCD的完全/部分成功率为80%。
  • 自体LSCT的成功率显著高于异体LSCT(p=0.048)。
  • 术后最佳矫正视力(logMAR)显著改善(p=0.009)。

核心结论

  • 采用真空干燥羊膜和纤维蛋白胶的改良ACER联合LSCT是全LSCD有效的眼表重建技术,可改善视力。
  • 真空干燥羊膜具有易于操作、透明和室温储存的优点。

研究设计与样本

  • 回顾性、干预性病例系列研究,纳入2016–2019年接受改良ACER联合LSCT的所有全LSCD患者,共10例(6男),平均年龄46.2±18.4岁,平均随访23.0±13.9个月。

主要发现

  • 80%的患者在ACER后达到完全或部分成功,20%的患者需要重复LSCT。
  • 自体LSCT与显著更高的成功率相关(p=0.048)。
  • 平均最佳矫正视力(logMAR)从术前1.76±0.64显著改善至末次随访0.94±0.94(p=0.009)。
  • LSCD病因包括化学性眼外伤(30%)、先天性无虹膜相关角膜病变(30%)、眼表恶性肿瘤(20%)、Steven-Johnson综合征(10%)和接触镜过度使用(10%);50%为双侧。
  • 对于获得性病因,从诊断到ACER的时间为45.6±44.4个月。

关键数值与推荐

  • 成功定义为完全角膜再上皮化无结膜化;部分成功定义为亚全角膜再上皮化伴部分非进展性结膜化但未累及视轴;失败定义为结膜化累及视轴。

临床怎么用

  • 改良ACER联合LSCT可用于全LSCD的眼表重建,自体LSCT可能提高成功率。
  • 真空干燥羊膜(Omnigen)可室温即用储存,其透明性便于观察下方愈合上皮。

局限性

  • 回顾性病例系列,样本量小(10例),随访时间有限,需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study the outcome of a modified amnion-assisted conjunctival epithelial redirection (ACER) technique using vacuum-dried amnion (Omnigen) and fibrin glue for managing total limbal stem cell deficiency (LSCD). METHOD: A retrospective, interventional case series of all patients with total LSCD who underwent limbal stem cell transplant (LSCT) using the modified ACER procedure between 2016 and 2019. The outcome was defined as: (1) success: complete corneal re-epithelialisation without conjunctivalisation; (2) partial success: sub-total corneal re-epithelialisation with partial non-progressive conjunctivalisation sparing the visual axis and (3) failure: conjunctivalisation affecting the visual axis. RESULTS: Ten patients (six men), with a mean age of 46.2±18.4 years, were included. The mean follow-up was 23.0±13.9 months. Causes of LSCD were chemical eye injury (30%), congenital aniridia-related keratopathy (30%), ocular surface malignancy (20%), Steven-Johnson syndrome (10%) and contact lens overuse (10%). 50% were bilateral. The time from diagnosis to ACER (for acquired causes) was 45.6±44.4 months. 80% of patients achieved a complete/partial success following ACER and 20% of patients required repeat LSCT. Auto-LSCT was associated with a significantly higher chance of success than allo-LSCT (p=0.048). The mean best-corrected-visual-acuity (logMAR) improved significantly from 1.76±0.64 preoperatively to 0.94±0.94 at final follow-up (p=0.009). Omnigen was available off-the-shelf stored at room temperature and its transparency enabled visualisation of the healing epithelium beneath. CONCLUSION: LSCT using the modified ACER serves as an effective ocular surface reconstruction technique in managing total LSCD and improving vision. Vacuum-dried amnion provides advantages of easy handling, transparency and storage at room temperature.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Dua HS, Ting DSJ, AlSaadi A, et al. Management of limbal stem cell deficiency by amnion-assisted conjunctival epithelial redirection using vacuum-dried amniotic membrane and fibrin glue. Br J Ophthalmol. 2021. PMID: 34610946. doi:10.1136/bjophthalmol-2020-318496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。